UNLIMITED TURBO LONG - QUEST DIAGNOSTICS | Market Closed - Boerse Frankfurt Warrants 20:50:30 28/06/2024 BST | ||
| 3.2 EUR | -4.48% |
|
| Current month | -11.41% | ||
| 1 month | -8.17% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 3.26 | -2.69% |
| 27/06/24 | 3.35 | -2.90% |
| 26/06/24 | 3.45 | -0.29% |
| 25/06/24 | 3.46 | -4.42% |
| 24/06/24 | 3.62 | +2.84% |
Real-time Boerse Frankfurt Warrants
Last update June 28, 2024 at 08:50 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PZ0ZFP |
| ISIN | DE000PZ0ZFP5 |
| Date issued | 03/11/2023 |
| Strike | 105.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.19 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.15 € |
|---|---|
| Lowest since issue | 2.23 € |
| Spread | 0.02 € |
| Spread % | 0.62% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
136.9
USD
Average target price
147
USD
Spread / Average Target
+7.39%
- Stock Market
- Certificates
- Certificat
